DF
GMED icon

Donoghue Forlines’s Globus Medical GMED Stock Holding History

Donoghue Forlines’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-48,257
Closed -$2.47M – 172
2019
Q3 		$2.47M Buy
+48,257
New +$2.3M 0.35% 85

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Donoghue Forlines's GMED Position: Q4 2019 in Review

Donoghue Forlines sold out of Globus Medical (GMED) in Q4 2019, closing a stake of 48,257 shares — an estimated $2.47M sold.

Donoghue Forlines first reported a position in GMED in Q3 2019 and held it in 1 quarter. The position peaked at $2.47M in Q3 2019. 307 funds tracked by Wall St. Rank hold GMED as of Q4 2019.

  • Donoghue Forlines reported no remaining Globus Medical position as of Q4 2019 after selling out during the quarter.
  • Donoghue Forlines sold 48,257 Globus Medical shares in Q4 2019, an estimated $2.47M.
  • Donoghue Forlines first reported a position in Globus Medical in Q3 2019 and held it in 1 quarter.
  • Donoghue Forlines's Globus Medical position peaked at $2.47M in Q3 2019.
  • 307 funds tracked by Wall St. Rank held Globus Medical as of Q4 2019.

Based on Donoghue Forlines's 13F filing for Q4 2019, filed 27 Jan 2020.